6. Cencora, Inc. (NYSE:COR)
Number of Hedge Fund Holders: 61
Cencora, Inc. (NYSE:COR) is the next best Robinhood stock on this list.
TheFly reported on March 23 that COR revealed that it has signed a binding agreement to acquire the retina division of EyeSouth Partners for $1.1 billion. Once the deal closes, EyeSouth’s affiliated retina physicians will become part of COR’s Retina Consultants of America, a leading management services organization. The acquisition integrates a strong regional physician network into COR’s operations, enhancing the company’s ability to deliver advanced retina care. Cencora, Inc. (NYSE:COR) emphasizes that this move will combine EyeSouth’s established clinical expertise with RCA’s organizational support, aiming to provide high-quality patient care while reinforcing Cencora’s commitment to backing community-based ophthalmologists across its expanding network.
Separately, on March 17, COR confirmed its fiscal 2026 adjusted diluted EPS outlook, maintaining a range of $17.45 to $17.75. This reaffirmation coincides with the announcement that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. An executive search firm has been retained to identify potential successors, with Cleary assisting in the process and remaining in an advisory role through the end of 2026 to ensure a smooth leadership transition.
Cleary, who has been COR’s CFO since 2018 and part of the company since 2015, leaves after a distinguished tenure contributing to strategic growth and shareholder value. The company expressed appreciation for his leadership and emphasized confidence in the organization’s ongoing financial and operational stability, underscoring that the reaffirmed EPS guidance reflects the company’s commitment to delivering consistent results for fiscal year 2026.
Cencora, Inc. (NYSE:COR) is a global pharmaceutical distributor and healthcare services company that supplies medications, medical products, and value‑added solutions to pharmacies, hospitals, and long‑term care providers to improve patient care and outcomes.
While we acknowledge the potential of COR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than COR and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Stocks to Invest In on Robinhood for Beginners.
Disclosure: None. Follow Insider Monkey on Google News.
